Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Francisco Chacon-Lozsan: Why Anticoagulation in the ICU is not One Protocol?
Francisco Chacón-Lozsán/LinkedIn
May 28, 2026, 16:06

Francisco Chacon-Lozsan: Why Anticoagulation in the ICU is not One Protocol?

Francisco Chacon-Lozsan, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine (ESICM) and American College of Cardiology, shared a post on X  about recent article by Mark A. Creager et al., published in Circulation, adding:

“Anticoagulation in the ICU is not one protocol.

It is a daily balance between thrombosis, bleeding, renal clearance, procedure timing, and the reason for anticoagulation.

Recent PubMed indexed guidance reinforces that critically ill patients need systematic VTE prophylaxis unless bleeding risk is prohibitive (Bounes et al., 2024; Arabi & Mehta, 2025).

But dose is context.

Standard ICU prophylaxis is often enoxaparin 40 mg once daily or UFH 5000 IU every 8 to 12 hours.

In obesity, fixed low dosing may underdose patients, reflecting the need for higher or weight adjusted prophylaxis in selected patients (Arcelus et al., 2024).

In AKI or severe CKD, UFH is often safer than LMWH because accumulation is less problematic and reversal is easier.

Therapeutic anticoagulation is a different question.

AF in the ICU requires stroke risk, bleeding risk, rhythm duration, procedures, renal function, and enteral absorption assessment.

The 2023 ACC,AHA,ACCP,HRS AF guideline supports DOACs over warfarin for most non valvular AF, but not for mechanical valves or moderate to severe rheumatic mitral stenosis (Joglar et al., 2023).

PE in shock is not ‘just anticoagulation.’ It is anticoagulation plus reperfusion assessment.

The 2026 AHA, ACC multisociety PE guideline focuses on risk stratification, anticoagulation, catheter based therapy, thrombolysis, surgical embolectomy, and IVC filters when anticoagulation is impossible (AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM Writing Committee, 2026).

Mechanical valves remain warfarin territory.

DOACs are not substitutes.

Bridging decisions must consider valve type, position, prior stroke, AF, LV dysfunction, and bleeding risk.

Liver failure is not ‘auto anticoagulated.’

Cirrhosis creates rebalanced but fragile hemostasis.

Hospitalized cirrhotic patients can thrombose and may still need prophylaxis or treatment when bleeding risk is controlled (Roark et al., 2024).

Recent stroke, major surgery, ACS, elderly frailty, thrombocytopenia, and renal dysfunction all change the equation.

Mechanical prophylaxis may be useful when pharmacological prophylaxis is temporarily unsafe, and a 2024 meta analysis supports intermittent pneumatic compression as an option in surgical patients, especially when bleeding risk limits anticoagulants (Kim et al., 2024).”

Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Authors: Mark A. Creager, Geoffrey D. Barnes, Jay Giri, Debabrata Mukherjee, William Schuyler Jones, Allison E. Burnett, Teresa Carman, Ana I. Casanegra, Lana A. Castellucci, Sherrell M. Clark, Mary Cushman, Kerstin de Wit, Jennifer M. Eaves, Margaret C. Fang, Joshua B. Goldberg, Stanislav Henkin, Hillary Johnston-Cox, Sabeeda Kadavath, Daniella Kadian-Dodov, William Brent Keeling, Andrew J.P. Klein, Jun Li, Michael C. McDaniel, Lisa K. Moores, Gregory Piazza, Karen S. Prenger, Steven C. Pugliese, Mona Ranade, Rachel P. Rosovsky, Farla Russo, Eric A. Secemsky, Akhilesh K. Sista, Leben Tefera, Ido Weinberg, Lauren M. Westafer, Michael N. Young

Francisco Chacón-Lozsán

Stay updated on all scientific advances with Hemostasis Today.

ACC ACCP AHA Akhilesh K. Sista Allison E. Burnett Ana I. Casanegra Andrew J. P. Klein Daniella Kadian-Dodov Debabrata Mukherjee Eric A. Secemsky Farla Russo Geoffrey D. Barnes Gregory Piazza Health Hematology Hemostasis Hemostasis News Hemostasis Today Hillary Johnston-Cox HRS AF Ido Weinberg Jay Giri Jennifer M. Eaves Joshua B. Goldberg Jun Li Karen S. Prenger Kerstin de Wit Lana A. Castellucci Lauren M. Westafer Leben Tefera Lisa K. Moores Margaret C. Fang Mark A. Creager Mary Cushman Medicine Michael C. McDaniel Michael N. Young Mona Ranade Rachel P. Rosovsky Sabeeda Kadavath Sherrell M. Clark Stanislav Henkin Steven C. Pugliese Teresa Carman VTE William Brent Keeling William Schuyler Jones
NewsFeed